$22.03
In chiusura: Sep 2 EDT
$21.99
-0.04-0.18%
Pre-mercato: 7:22 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Arrowhead Pharma segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 25
Stima EPS
$-0.180
Stima dei ricavi trimestrali
$170.17M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$572.98M
Analizza lo storico degli utili di Arrowhead Pharma utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARWR | Arrowhead Pharma | -$1.37 | -$0.18 | — | — | $0.00 | $170.17M | — | — | 11/25/2025 | |
ARWR | Arrowhead Pharma | -$1.38 | -$1.04 | -$1.26 | -21.15% | $0.00 | $33.78M | $27.77M | -17.80% | 08/07/2025 | |
ARWR | Arrowhead Pharma | -$1.02 | -$0.46 | $2.75 | 697.83% | $0.00 | $116.27M | $542.71M | 366.77% | 05/12/2025 | |
ARWR | Arrowhead Pharma | -$1.24 | -$0.72 | -$1.39 | -93.06% | $3.55M | $19.05M | $2.50M | -86.88% | 02/10/2025 | |
ARWR | Arrowhead Pharma | -$1.02 | -$0.92 | -$1.37 | -48.91% | $16.10M | $58.91M | $0.00 | -100.00% | 11/26/2024 | |
ARWR | Arrowhead Pharma | -$0.96 | -$0.55 | -$1.38 | -150.91% | $15.82M | $52.63M | $0.00 | -100.00% | 08/08/2024 | |
ARWR | Arrowhead Pharma | $0.45 | -$0.16 | -$1.02 | -537.50% | $146.27M | — | $0.00 | — | 05/09/2024 | |
ARWR | Arrowhead Pharma | -$0.39 | -$0.82 | -$1.24 | -51.22% | $62.55M | $29.51M | $3.55M | -87.97% | 02/06/2024 | |
ARWR | Arrowhead Pharma | -$0.81 | -$0.60 | -$1.02 | -70.00% | $31.57M | $50.73M | $16.10M | -68.27% | 11/29/2023 | |
ARWR | Arrowhead Pharma | -$0.68 | -$0.58 | -$0.96 | -65.52% | $32.41M | $48.19M | $15.82M | -67.16% | 08/07/2023 | |
ARWR | Arrowhead Pharma | $0.41 | -$0.64 | $0.45 | 170.31% | $151.81M | $45.48M | $146.27M | 221.61% | 05/02/2023 | |
ARWR | Arrowhead Pharma | -$0.60 | $0.44 | -$0.39 | -188.64% | $27.44M | $162.52M | $62.55M | -61.51% | 02/06/2023 | |
ARWR | Arrowhead Pharma | -$0.61 | -$0.16 | -$0.81 | -406.25% | $38.28M | $50.44M | $31.57M | -37.40% | 11/28/2022 | |
ARWR | Arrowhead Pharma | -$0.29 | -$0.51 | -$0.68 | -33.33% | $45.89M | $55.23M | $32.41M | -41.31% | 08/04/2022 | |
ARWR | Arrowhead Pharma | -$0.26 | -$0.08 | $0.41 | 612.50% | $32.81M | $108.91M | $151.81M | 39.39% | 05/10/2022 | |
ARWR | Arrowhead Pharma | -$0.20 | -$0.45 | -$0.60 | -33.33% | $21.30M | $51.04M | $27.44M | -46.24% | 02/02/2022 | |
ARWR | Arrowhead Pharma | -$0.48 | -$0.10 | -$0.61 | -510.00% | $7.63M | $56.77M | $38.28M | -32.56% | 11/22/2021 | |
ARWR | Arrowhead Pharma | -$0.13 | -$0.20 | -$0.29 | -45.00% | $27.38M | $37.52M | $45.89M | 22.31% | 08/05/2021 | |
ARWR | Arrowhead Pharma | -$0.20 | -$0.13 | -$0.26 | -100.00% | $23.53M | $37.70M | $32.81M | -12.97% | 05/04/2021 | |
ARWR | Arrowhead Pharma | -$0.03 | $0.17 | -$0.20 | -217.65% | $29.45M | $86.69M | $21.30M | -75.43% | 02/04/2021 | |
ARWR | Arrowhead Pharma | $0.11 | $0.12 | -$0.48 | -500.00% | $43.29M | $49.24M | $7.63M | -84.50% | 11/23/2020 |
Arrowhead Pharma (ARWR) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-08-07 | $-1.26 | $-1.04 | -21.1 % |
| Q2 | 2025-05-12 | $2.75 | $-0.46 | 697.8 % |
| Q1 | 2025-02-10 | $-1.39 | $-0.72 | -93.1 % |
| Q4 | 2024-11-26 | $-1.37 | $-0.92 | -48.9 % |
Arrowhead Pharma (ARWR) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-08-07 | $27.77M | $33.78M | -17.8 % |
| Q2 | 2025-05-12 | $542.71M | $116.27M | 366.8 % |
| Q1 | 2025-02-10 | $2.50M | $19.05M | -86.9 % |
| Q4 | 2024-11-26 | $0 | $58.91M | -100.0 % |
FAQ
Quando Arrowhead Pharma (NASDAQ:ARWR) riporterà gli utili?
Si prevede che Arrowhead Pharma (ARWR) fornisca risultati il novembre 25, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Arrowhead Pharma (NASDAQ:ARWR)?
L'EPS effettivo era $-1.26, che mancato la stima di $-1.04.
Quali sono state le entrate di Arrowhead Pharma (NASDAQ:ARWR)?
Le entrate effettive sono state $27.8M, che mancato la stima di $33.8M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.